HysensBio Co.
Latest round
- Series C
Last raised
- May 2021
Total raised
- $19M
Investors
- 9
About HysensBio Co.
, Ltd. focuses on transforming dental treatments. The founder, Joo-cheol Park, has a history of entrepreneurship that contributes to HysensBio's direction and strategies.HysensBio specializes in developing therapeutic solutions, including KH-001, KH-002, and HBO-001, which target odontoblasts and periodontal ligament fibroblasts.6 million. The company is also targeting expansion into new markets across Asia by the end of 2024, leveraging recent investments to support these growth initiatives and the anticipated IPO listing with the Korea Exchange.
Who invested in HysensBio Co.
9 investors across 3 rounds
See all investors in HysensBio Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about HysensBio Co.
Who invested in HysensBio Co.?
HysensBio Co. has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HysensBio Co. raised?
HysensBio Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did HysensBio Co. last raise money?
HysensBio Co.'s most recent round on record is a Series C, in May 2021.
What does HysensBio Co. do?
HysensBio Co. is a healthcare specialists company.
Where is HysensBio Co. headquartered?
HysensBio Co. is headquartered in Gwacheon, South Korea.
Which VCs invest in companies like HysensBio Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back healthcare specialists companies at HysensBio Co.'s stage. Their profiles are linked below.
VCs backing healthcare specialists startups at Series C
Raising like HysensBio Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.